This company has been marked as potentially delisted and may not be actively trading. Alimera Sciences (ALIM) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ALIM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Alimera Sciences Inc.March 19, 2025 | money.usnews.comANI Pharmaceuticals’ Record Growth and Strategic AcquisitionNovember 9, 2024 | markets.businessinsider.comAlimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.comSeptember 22, 2024 | marketbeat.comANI Pharmaceuticals’ Acquisition of Alimera Sciences Bolsters Buy Rating and $94 Target PriceSeptember 18, 2024 | markets.businessinsider.comAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest UpdateSeptember 16, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?September 12, 2024 | finance.yahoo.comAlimera Sciences, Inc. (ALIM)September 11, 2024 | finance.yahoo.comAlimera Sciences: Deal Closing After All, CVR Still AttractiveSeptember 11, 2024 | seekingalpha.comANI Pharmaceuticals, Alimera Sciences deal set to close MondaySeptember 11, 2024 | msn.comAlimera Sciences Shares Slide on Merger LawsuitSeptember 10, 2024 | marketwatch.comAlimera Files Lawsuit Against ANI To Enforce Merger Deal, Stock Down Nearly 19%September 10, 2024 | markets.businessinsider.comAlimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger AgreementSeptember 10, 2024 | finance.yahoo.comANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera SciencesSeptember 10, 2024 | finance.yahoo.comAlimera Sciences plunges after it sues ANI Pharmaceuticals to close dealSeptember 10, 2024 | msn.comAlimera Sciences (NASDAQ:ALIM) Coverage Initiated at StockNews.comAugust 29, 2024 | marketbeat.comALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera ...August 20, 2024 | businesswire.comVanguard Group Inc. Grows Stake in Alimera Sciences, Inc. (NASDAQ:ALIM)August 19, 2024 | marketbeat.comDeltec Asset Management LLC Invests $690,000 in Alimera Sciences, Inc. (NASDAQ:ALIM)August 14, 2024 | marketbeat.comShould You Invest on Alimera Sciences, Inc. (ALIM) Right Now?August 9, 2024 | msn.comAlimera Sciences (NASDAQ:ALIM) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSAugust 7, 2024 | marketbeat.comAlimera Sciences Reports Second Quarter 2024 ResultsAugust 6, 2024 | globenewswire.comALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.July 27, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJuly 26, 2024 | prnewswire.comInvesting in Alimera Sciences (NASDAQ:ALIM) a year ago would have delivered you a 68% gainJuly 25, 2024 | finance.yahoo.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Increase in Short InterestJuly 25, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Up 142.1% in JuneJuly 12, 2024 | marketbeat.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIMJuly 3, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJuly 2, 2024 | prnewswire.comAlimera Sciences' (ALIM) Neutral Rating Reaffirmed at Alliance Global PartnersJune 25, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by HC Wainwright to NeutralJune 25, 2024 | marketbeat.comShareholder Alert: Ademi LLP investigates whether Alimera Sciences, Inc. has obtained a Fair Price for its Public ShareholdersJune 24, 2024 | prnewswire.comWhy Is Alimera Sciences (ALIM) Stock Up 77% Today?June 24, 2024 | investorplace.comALIM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Alimera Sciences to ANI PharmaceuticalsJune 24, 2024 | globenewswire.comALIM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to ShareholdersJune 24, 2024 | businesswire.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Significant Growth in Short InterestJune 15, 2024 | marketbeat.comAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 4, 2024 | globenewswire.comHC Wainwright Research Analysts Cut Earnings Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM)May 17, 2024 | marketbeat.comRobust Growth and Promising Trials: Buy Rating for Alimera SciencesMay 16, 2024 | markets.businessinsider.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by HC WainwrightMay 16, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Issues Earnings Results, Misses Estimates By $0.08 EPSMay 15, 2024 | marketbeat.comAlimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...May 15, 2024 | finance.yahoo.comAlimera Sciences Reports First Quarter 2024 ResultsMay 14, 2024 | globenewswire.comAlimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress ConferencesMay 7, 2024 | finance.yahoo.comAlimera Sciences (ALIM) to Release Earnings on TuesdayMay 7, 2024 | marketbeat.comAlimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateApril 30, 2024 | finance.yahoo.comStockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to HoldApril 30, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews.comApril 22, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Growth in Short InterestApril 13, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to "Hold"April 12, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Lifted to Buy at StockNews.comApril 4, 2024 | marketbeat.com Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address ALIM Media Mentions By Week ALIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALIM News Sentiment▼0.000.96▲Average Medical News Sentiment ALIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALIM Articles This Week▼00▲ALIM Articles Average Week Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELVN News Today GPCR News Today CDTX News Today ARDX News Today PRAX News Today PROK News Today COLL News Today AKBA News Today AMPH News Today RCUS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALIM) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
